Mid Day Stocks on Watch (APP, SBRH, ICAD, CRNT, PHC, CTIC, ELGX, AVII)
American Apparel Inc. (Public, AMEX:APP) - Shares have been breaking out on a bullish chart today as APP announced that it is set to renegotiate debt covenants. Along with the market being a green and shorts covering, APP chart is looking very fashionable today!
SEBASTIAN RIVER HLDGS (PINK:SBRH) - Since we bounced about this last week, the volatility has incredible. Shares dropped down 50% on Friday, to only move up again 740% today to $.21. The float is ridiculously small and micro cap investors are chasing the ask, which seems to keep moving up big time. Stay tune for more updates.
iCAD, INC. (NASDAQ: ICAD) - ICAD is up 11% with a high of $1.80 so far today on news that it has signed a sales agreement with Defense Supply Center. The contract is to provide the company's Computer aided Detection technology for mammography to federal healthcare facilities. The products with be installed in Veteran's administrations and department of defenses hospitals to expand its over 400 federal facilities already using the product.
Ceragon Networks Ltd. (NASDAQ: CRNT) - CRNT is up 17% today with a high of 8.60 so far today off news that Digitel Mobile Philippines will invest an additional $9 million. Ceragon is the provider of high-capacity, 4G/LTE-Ready wireless backhaul solutions and fastest growing mobile telecommunications provider in the Republic of the Philippines.
PHC, Inc. (AMEX: PHC) - PHC has authorized the repurchase of up to one million shares of its Class A common stock for a one-year period commencing July 1, 2010. The company's previous stock buyback program is scheduled to expire June 30, 2010. PHC is up 20% of the new an hit a high of $1.21 today.
Cell Therapeutics, Inc. (NASDAQ: CTIC) - Cell Therapeutics has begun it analysis of its pivotal drug of Pixuvri(TM) (pixantrone dimaleate), the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin lymphoma ("NHL"). The study showed a 21% improvement over competitive drugs in patient survival rate as initial result indicate. The Stock is up 15% today with a high of $.54 so far continuing the bullish outlook for the stock over the past week.
Endologix, Inc. (NASDAQ: ELGX) - Endologix has received U.S. Food and Drug Administration (FDA) approval for its expanded offering of “Powerlink” stent graft products. This covers 31 new sizes of “Powerlink” main body bifurcated, proximal extension, and limb extension stent grafts. The stock is up 10% to $5.07 at the high so far today of the increased potential market size.
AVI BioPharma, Inc. (NASDAQ: AVII) - AVI is up 10% to a high of $1.67 so far of no new announcements. AVI BioPharma has no product on the market but has been releasing favorable results from studies such as there drug to treat genetic muscle-wasting disease. The Barron's reports that the company is looking for a large investment partner to help expand there testing.
News 
Market Data 
Discover 
AI
